Selda Samakoglu
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 10%
- Virus-based gene therapy research
- Hemoglobinopathies and Related Disorders
Papers in
- Genetics 3
- Virus-based gene therapy research 4
- Hemoglobinopathies and Related Disorders 3
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- Scott J. Rodig (2 shared papers)Philippe A. Armand (2 shared papers)John M. Timmerman (2 shared papers)Anne Sumbul (2 shared papers)Stephen Maxted Ansell (2 shared papers)Peter Johnson (2 shared papers)Jonathon Brett Cohen (1 shared paper)Monique C. Minnema (1 shared paper)
- Journals
- Blood (2 papers)Best Practice & Research Clinical Haematology (1 paper)Gene Therapy (1 paper)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Selda Samakoglu
14 papers receiving 683 citations
Selda Samakoglu's Hit Papers
Peers
Comparison fields: 5 of 25
- Pathology and Forensic Medicine 234
- Genetics 56
- Oncology 116
- Genetics 56
- Biotechnology 9
Countries citing papers authored by Selda Samakoglu
This map shows the geographic impact of Selda Samakoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selda Samakoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selda Samakoglu more than expected).
Fields of papers citing papers by Selda Samakoglu
This network shows the impact of papers produced by Selda Samakoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selda Samakoglu. The network helps show where Selda Samakoglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Selda Samakoglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study Hit paper breakdown → | 2019 | 302 |
| 2 | 2005 | 97 | |
| 3 | 2020 | 81 | |
| 4 | 2019 | 70 | |
| 5 | 2005 | 28 | |
| 6 | Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC. | 2012 | 22 |
| 7 | 2001 | 21 | |
| 8 | 2002 | 18 | |
| 9 | 1999 | 17 | |
| 10 | 2011 | 17 | |
| 11 | 2004 | 16 | |
| 12 | 2008 | 3 | |
| 13 | Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models. | 2011 | 2 |
| 14 | 2021 | 2 |
About Selda Samakoglu
Selda Samakoglu is a scholar working on Genetics, Genetics, Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 696 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Hemoglobinopathies and Related Disorders (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (234 citations), Genetics (56 citations), Oncology (116 citations), Genetics (56 citations) and Biotechnology (9 citations). Selda Samakoglu has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Scott J. Rodig, Philippe A. Armand, John M. Timmerman, Anne Sumbul, Stephen Maxted Ansell, Peter Johnson, Jonathon Brett Cohen, Monique C. Minnema, Manish R. Sharma and Sarit E. Assouline. Their work appears in journals such as Blood, Best Practice & Research Clinical Haematology, Gene Therapy, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.